bigmarketresearch.com include new market research report “Future of the Global Glioblastoma Multiforme Therapeutics Market 2015-2019 – Market Attractiveness, Competitive Landscape and Forecasts to 2021″ to its huge collection of research reports.
About Glioblastoma Multiforme
Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain tumor happens due to uncontrolled cell division and developments in the brain. The tumors can be found in the glial cells or the neuron. The one which develops in the glial cells (astrocytes and oligodendrocytes) is called glioma, the commonest forms of brain tumor.
Glioblastoma multiforme is the most common variant of brain tumor, and highly invasive in nature. It may turn up in the cerebrum, mostly in the frontal and temporal lobes, and seldom spreads in areas outside the brain. The tumor progresses rapidly, and is among the most difficult-to-treat cancer with limited treatment options.
Glioblastoma multiforme can be treated by chemotherapy, steroids, radiation therapy, proton therapy, surgical procedure, and immunotherapies, which are the emerging treatment options yet to hit the market. Analysts forecast the global glioblastoma multiforme therapeutics market to grow at a CAGR of 11.94 percent during 2014-2019.
Download sample copy here @ http://www.bigmarketresearch.com/request-sample/320976
Based on the route of administration of the drugs used to treat glioblastoma multiforme, the market is segmented as follows:
Based on the type of molecules of the drugs used to treat glioblastoma multiforme, the market is segmented as follows:
• Small Molecules
This report includes a discussion on the market in the following three regions:
• The Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil
• EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries, such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
• APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India
The vendor landscape includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, we discuss the major drivers influencing market growth and also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
Request for discount here @ http://www.bigmarketresearch.com/purchase-enquiry/320976
• Arbor Pharmaceuticals
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Lack of Treatment Options for Glioblastoma Multiforme
• For a full and detailed list, view our report
Contact Us :
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
Direct :+ 1-503-894-6022
Toll Free : + 1-800-910-6452